Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Cost of Revenue: 2010-2025

Historic Cost of Revenue for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to $199.1 million.

  • Cross Country Healthcare's Cost of Revenue fell 2065.5% to $199.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $899.9 million, marking a year-over-year decrease of 2143.09%. This contributed to the annual value of $1.1 billion for FY2024, which is 3183.33% down from last year.
  • According to the latest figures from Q3 2025, Cross Country Healthcare's Cost of Revenue is $199.1 million, which was down 2065.5% from $218.1 million recorded in Q2 2025.
  • Cross Country Healthcare's Cost of Revenue's 5-year high stood at $613.9 million during Q1 2022, with a 5-year trough of $199.1 million in Q3 2025.
  • Its 5-year average for Cost of Revenue is $356.4 million, with a median of $301.9 million in 2024.
  • Its Cost of Revenue has fluctuated over the past 5 years, first surged by 20613.28% in 2021, then tumbled by 3753.63% in 2024.
  • Quarter analysis of 5 years shows Cross Country Healthcare's Cost of Revenue stood at $493.5 million in 2021, then fell by 0.86% to $489.3 million in 2022, then plummeted by 33.87% to $323.5 million in 2023, then dropped by 23.37% to $247.9 million in 2024, then decreased by 19.69% to $199.1 million in 2025.
  • Its last three reported values are $199.1 million in Q3 2025, $218.1 million for Q2 2025, and $234.8 million during Q1 2025.